Drug Profile
Bromopyruvate - PreScience Labs
Alternative Names: 3-bromopyruvate; 3-bromopyruvic acid; 3-BrPA; 3BP; KAT 3-BP; KAT-101; KAT-201; KAT/3BP; PSL-001Latest Information Update: 20 Dec 2023
Price :
$50
*
At a glance
- Originator Johns Hopkins University
- Developer NewG Lab; PreScience Labs
- Class Antineoplastics; Keto acids; Pyruvates; Small molecules
- Mechanism of Action Alkylating agents; MASP2 protein inhibitors; Pyruvate dehydrogenase complex inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Pancreatic cancer
- Preclinical Lymphoma
- Discontinued Cancer